The Cardioprotective Potential of Herbal Formulas in Myocardial Infarction-Induced Heart Failure through Inhibition of JAK/STAT3 Signaling and Improvement of Cardiac Function
Pharmaceuticals · 27.08.2024 · 17 (9) · 1132
DOI: 10.3390/ph17091132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 27.08.2024. Verfasst von Youn-Jae Jang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hanbang Cardio-Renal Syndrome Research Center, Wonkwang University, Iksan 54538, Republic of Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Myocardial infarction (MI) is a leading cause of heart failure, characterized by adverse cardiac remodeling. This study evaluated the cardioprotective potential of Dohongsamul-tang (DHT), a traditional Korean herbal formula, in a rat model of MI-induced heart failure. Rats underwent left anterior descending (LAD) artery ligation and were treated with either 100 mg/kg or 200 mg/kg of DHT daily for 8 weeks. DHT treatment significantly improved cardiac function, as evidenced by increased ejection fraction (EF) from 62.1% to 70.1% (100 mg/kg) and fractional shortening (FS) from 32.3% to 39.4% (200 mg/kg) compared to the MI control group. Additionally, DHT reduced infarct size by approximately 63.3% (from 60.0% to 22.0%) and heart weight by approximately 16.7% (from 3.6 mg/g to 3.0 mg/g), and significantly decreased levels of heart failure biomarkers: LDH was reduced by 37.6% (from 1409.1 U/L to 879.1 U/L) and CK-MB by 47.6% (from 367.3 U/L to 192.5 U/L). Histological analysis revealed a reduction in left ventricle (LV) fibrosis by approximately 50% (from 24.0% to 12.0%). At the molecular level, DHT inhibited the expression of phospho-JAK by 75% (from 2-fold to 0.5-fold), phospho-STAT3 by 30.8% (from 1.3-fold to 0.9-fold), Bax/Bcl-2 by 56.3% (from 3.2-fold to 1.4-fold), and caspase-3 by 46.3% (from 1.23-fold to 0.66-fold). These results suggest that DHT exerts cardioprotective effects by modulating the JAK/STAT3 signaling pathway, highlighting its potential as a therapeutic option for heart failure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hanbang Cardio-Renal Syndrome Research Center, Wonkwang University, Iksan 54538, Republic of Korea.
- College of Oriental Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan 54538, Republic of Korea.
ORCID-Profile: Hye-Yoom Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Jang, Y. J., Kim, H. Y., Na, S. W., Hong, M. H., Yoon, J. J., Lee, H. S., & Kang, D. G. (2024). The Cardioprotective Potential of Herbal Formulas in Myocardial Infarction-Induced Heart Failure through Inhibition of JAK/STAT3 Signaling and Improvement of Cardiac Function. Pharmaceuticals, 17(9), 1132. https://doi.org/10.3390/ph17091132
Vancouver
Jang YJ, Kim HY, Na SW, Hong MH, Yoon JJ, Lee HS, et al. The Cardioprotective Potential of Herbal Formulas in Myocardial Infarction-Induced Heart Failure through Inhibition of JAK/STAT3 Signaling and Improvement of Cardiac Function. Pharmaceuticals. 2024;17(9):1132. doi:10.3390/ph17091132
BibTeX
@article{Jang2024,
author = {Jang, Youn-Jae and Kim, Hye-Yoom and Na, Se-Won and Hong, Mi-Hyeon and Yoon, Jung-Joo and Lee, Ho-Sub and Kang, Dae-Gill},
title = {The Cardioprotective Potential of Herbal Formulas in Myocardial Infarction-Induced Heart Failure through Inhibition of JAK/STAT3 Signaling and Improvement of Cardiac Function},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {9},
pages = {1132},
doi = {10.3390/ph17091132}
}
EUVIMED